Roche beefs up diagnostic arm with another bet on faster, cheaper DNA sequencing
While Roche pours half a billion dollars into its Covid-19 antibody test, the Swiss company is quietly beefing up the rest of their diagnostics arm …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
